Posted by Yasmin Hussain on Jun 19, 2020 12:00 pm
From what I read, triheptanoin was initially for patients with long‐chain fatty acid oxidation disorders. The they discovered that it was able to correct bioenergetics in the brain of patients with Huntington disease!